Clinical trial Recruiting at 1 site Observational Ages 2 to 50

Examining Neutrophils in Sepsis Patients

Official title: Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis

Run by Boston Children's Hospital · NCT04103281 · Data updated 2026-11-12

This study looks at the white blood cells called neutrophils in the blood and breathing tubes of sepsis patients to see how they behave and if they might be causing lung problems, with the hope of finding better treatments.

Quick facts

Study typeObservational
Ages2 Years to 50 Years
SexAll
Enrollment75 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedSeptember 1, 2020
Main results expectedJune 1, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 17, 2026
Trial IDNCT04103281 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include ICU patients diagnosed with sepsis who require a breathing tube.

Probably not a fit

Patients on chronic immunosuppressive drugs or with preexisting immunodeficiency diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the characteristics of neutrophils found in the blood and secretions from the breathing tubes of patients suffering from sepsis. Sepsis is a severe infection that can affect multiple body systems, and neutrophils play a crucial role in the immune response. By analyzing these white blood cells, researchers hope to understand their behavior and potential harmful effects in sepsis, which could lead to the development of targeted therapies to mitigate lung injury caused by these cells.

Why it matters

Potential benefit: If successful, this study could lead to improved therapies that prevent neutrophils from causing harm in sepsis patients.

How similar studies have gone: While the specific approach of examining neutrophil profiles in sepsis is novel, similar studies have shown promise in understanding immune responses in critical conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Case Inclusion Criteria:

* sepsis patient in the ICU with a breathing tube

Control Inclusion Criteria:

* scheduled for an elective surgical procedure and need preoperative blood draw or will have an intravenous catheter placed for the purpose of their surgical procedure
* Plan to have endotracheal tube for planned procedures.

Exclusion Criteria:

* On chronic immunosuppressive drugs such as chronic corticosteroid use, or preexisting immunodeficiency diseases (oncology patients, patients with transplantation)

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.